Genotype specific age related changes in a transgenic rat model of Huntington's disease
暂无分享,去创建一个
Ines Blockx | Marleen Verhoye | Annemie Van der Linden | Albertine Dubois | Nadja Van Camp | Raphael Boisgard | Bertrand Kuhnast | Kerstin Raber | Stephan Von Hörsten | Huu Phuc Nguyen | Elisabeth Jonckers | Frédéric Dollé | Benoit Jego | Karine Siquier | Bertrand Tavitian | M. Verhoye | I. Blockx | R. Boisgard | B. Jego | B. Tavitian | N. Camp | F. Dollé | E. Jonckers | A. Dubois | B. Kuhnast | H. Nguyen | S. Hörsten | K. Raber | K. Siquier | A. Linden
[1] Christopher A. Ross,et al. Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length , 2002, The Journal of Neuroscience.
[2] Erwan Dupont,et al. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy , 2010, Epilepsia.
[3] G. Pearlson,et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.
[4] Andreas Bauer,et al. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation , 2005, Journal of neurochemistry.
[5] P. Basser,et al. Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.
[6] Johan Nuyts,et al. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] Ronald Wetzel,et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.
[8] D. Eidelberg,et al. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] M. K. Das,et al. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. , 1995, Nuclear medicine and biology.
[10] P Jeffrey Conn,et al. [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot. , 2009, Nuclear medicine and biology.
[11] Philippe Hantraye,et al. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. , 2008, Current gene therapy.
[12] Paul Cumming,et al. Endogenous competition against binding of [18F]DMFP and [18F]fallypride to dopamine D2/3 receptors in brain of living mouse , 2010, Synapse.
[13] John L Bradshaw,et al. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[14] Jim Mintz,et al. Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.
[15] Christian Beaulieu,et al. Diffusion anisotropy in subcortical white matter and cortical gray matter: Changes with aging and the role of CSF‐suppression , 2004, Journal of magnetic resonance imaging : JMRI.
[16] Nick C Fox,et al. Increased rate of whole-brain atrophy over 6 months in early Huntington disease , 2006, Neurology.
[17] A. Aron,et al. Contrasting gray and white matter changes in preclinical Huntington disease , 2010, Neurology.
[18] Wilhelm Gaus,et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.
[19] Nick C Fox,et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.
[20] A. Leemans,et al. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract , 2009, NMR in biomedicine.
[21] Mario Mascalchi,et al. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. , 2004, Radiology.
[22] Francesca Cicchetti,et al. Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease , 2005, Journal of the Neurological Sciences.
[23] Young T. Hong,et al. Nucleus Accumbens D2/3 Receptors Predict Trait Impulsivity and Cocaine Reinforcement , 2007, Science.
[24] K. Lim,et al. Age‐related decline in brain white matter anisotropy measured with spatially corrected echo‐planar diffusion tensor imaging , 2000, Magnetic resonance in medicine.
[25] R. Ferrante,et al. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. , 2009, Biochimica et biophysica acta.
[26] V Bullman,et al. Automated three‐dimensional analysis of particle measurements using an optical profilometer and image analysis software , 2003, Journal of microscopy.
[27] R H Myers,et al. Quantitative neuropathological changes in presymptomatic Huntington's disease , 2001, Annals of neurology.
[28] C. Beaulieu,et al. Determinants of anisotropic water diffusion in nerves , 1994, Magnetic resonance in medicine.
[29] W C Eckelman,et al. Experiment assessment of mass effects in the rat: implications for small animal PET imaging. , 2004, Nuclear medicine and biology.
[30] Jan Sijbers,et al. A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease , 2012, Neurobiology of Aging.
[31] Jane S. Paulsen,et al. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[32] Marios Politis,et al. Hypothalamic involvement in Huntington's disease: an in vivo PET study. , 2008, Brain : a journal of neurology.
[33] Jogeshwar Mukherjee,et al. Evaluation of Dopamine D-2 Receptor Occupancy by Clozapine, Risperidone, and Haloperidol In Vivo in the Rodent and Nonhuman Primate Brain Using 18F-Fallypride , 2001, Neuropsychopharmacology.
[34] David F Meaney,et al. Traumatic Axonal Injury Results in Biphasic Calpain Activation and Retrograde Transport Impairment in Mice , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[36] Andrea Ciarmiello,et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] R N Gunn,et al. Huntington's disease progression. PET and clinical observations. , 1999, Brain : a journal of neurology.
[38] Nicola Pavese,et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. , 2003, Brain : a journal of neurology.
[39] David S Tuch,et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.
[40] Thomas Walther,et al. Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.
[41] R. Albin,et al. Rodent genetic models of Huntington disease , 2008, Neurobiology of Disease.
[42] Shu-Wei Sun,et al. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging , 2005, Experimental Neurology.
[43] G. Egan,et al. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.
[44] Yasin Temel,et al. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel , 2006, Behavioural Brain Research.
[45] Yasin Temel,et al. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats , 2006, Neurobiology of Disease.
[46] Kurt E. Weaver,et al. Longitudinal diffusion tensor imaging in Huntington's Disease , 2009, Experimental Neurology.
[47] A. Alexander,et al. Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.
[48] Olaf Riess,et al. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. , 2007, The Journal of comparative neurology.
[49] Derek K. Jones,et al. Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review , 2002 .
[50] John Missimer,et al. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[51] Jane S. Paulsen,et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.
[52] M. Senda,et al. KF 18446 PET in the rat brain after quinolinic acid lesion : Comparison with the dopamine receptor imaging , 2002 .
[53] Jane S. Paulsen,et al. Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.
[54] S. Aoki,et al. Magnetic resonance , 2012, International Journal of Computer Assisted Radiology and Surgery.
[55] Timothy Edward John Behrens,et al. In vivo evidence for the selective subcortical degeneration in Huntington's disease , 2009, NeuroImage.
[56] R H Myers,et al. Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus , 1991, Journal of neuropathology and experimental neurology.
[57] Elizabeth H. Aylward,et al. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease , 2007, Brain Research Bulletin.
[58] Sarah A. J. Reading,et al. Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study , 2005, Psychiatry Research: Neuroimaging.
[59] A. Rego,et al. Mechanisms of neurodegeneration in Huntington’s disease , 2008, The European journal of neuroscience.
[60] Andreas Bauer,et al. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. , 2008, Human molecular genetics.
[61] P. V. van Zijl,et al. A motion correction scheme by twin‐echo navigation for diffusion‐weighted magnetic resonance imaging with multiple RF echo acquisition , 1998, Magnetic resonance in medicine.
[62] J. Pruim,et al. Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease , 2005, Neurology.
[63] Olaf Riess,et al. Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease , 2007 .
[64] John Russell,et al. Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water , 2002, NeuroImage.
[65] Jogeshwar Mukherjee,et al. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [18F]fallypride and [18F]desmethoxyfallypride , 2011, Synapse.
[66] Vincent Frouin,et al. Automated Three-Dimensional Analysis of Histological and Autoradiographic Rat Brain Sections: Application to an Activation Study , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[67] Klaus Seppi,et al. Diffusion‐weighted imaging in Huntington's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[68] Jeffrey H Kordower,et al. Animal models of Huntington's disease. , 2007, ILAR journal.
[69] Alan C. Evans,et al. Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease , 2008, NeuroImage.
[70] Keiichi Oda,et al. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging , 2002, Annals of nuclear medicine.
[71] Jun Yoshino,et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain , 2005, NeuroImage.
[72] C. Beaulieu,et al. The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.
[73] B. Escalante,et al. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington’s disease mutation , 2002, Brain Research.
[74] Michael I. Miller,et al. Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images , 2010, NeuroImage.